Clinical Trial Update: Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated liposomal amphotericin B with or without sargramostim for invasive fungal infections; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infection

Drugs mentioned

• AMBISOME (AMPHOTERICIN B)
• sargramostim (sargramostim)

Snippet

Sponsor: Medical Research Council | Conditions: Infection | Phase 3 | Status: COMPLETED